Our Mission is saving lives.
Our focus is the patient Experience.

Our main focus is on the “patient experience” and bringing powerful therapies to market, in record time, at reasonable costs. It’s all about the patient who is Sitravon’s customer.

Click the “+” sign below to see some of our key focus areas at the corporate level that make Sitravon a market leader.

  • Clear regulatory hurdles and launch one new product introduction within this fiscal year for each therapeutic area resulting in the largest pipeline of commercially available therapies in the industry.

  • Attain YOY Revenue Growth of 25% from a mix of current and new therapeutics in all divisions that will exceed market expectations.

  • Impose tight guidelines on capital expenditures (CAPEX) resulting in a movement toward more operating expenditures (OPEX) resulting in an overall decrease of 20% budget spend.

  • Decrease overall time to database lock (and market) by 10% resulting in an increased overall run rate per month across all therapeutic areas.

  • Increase overall market share by 3.5% resulting in a total addressable market share capture increase across all therapeutic areas.

  • Over the next three years maximize resource investments through science, technology, and artificial intelligence resulting in a 20% increase in efficiency across the entire business.

  • Maintain strict adherence to corporate principles of good manufacturing practices (GMP) and good clinical practices (GCP), resulting in the company giving back 1% of profits, 1% of employee’s time, and 1% of products back to the healthcare community.

  • Sustainability is ingrained in our core values and operations. We prioritize environmentally responsible practices, from reducing waste in manufacturing processes to implementing energy-efficient initiatives, to ensure a healthier planet for future generations.